Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ADPKD (autosomal Dominant Polycystic Kidney Disease)”

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT07788014
What this trial is testing

Single and Multiple Ascending Doses of GV-100

Who this might be right for
ADPKD (Autosomal Dominant Polycystic Kidney Disease)
Gilva Therapeutics Inc. 80
Not applicableStudy completedNCT02084849
What this trial is testing

ADPKD Cohort Study

Who this might be right for
Autosomal Dominant Polycystic Kidney Disease
Emory University 624
Not applicableStudy completedNCT03948113
What this trial is testing

Outcome of Autosomal Dominant Polycystic Kidney Disease Patients on Peritoneal Dialysis: a National Retrospective Study Based on Two French Registries (the French Language Peritoneal Dialysis Registry and the French Renal Epidemiology and Information Network).

Who this might be right for
Polycystic Kidney Diseases
CHU de Reims 17,350
Not applicableStudy completedNCT05646420
What this trial is testing

Thyroid Hormones in ADPKD

Who this might be right for
Autosomal Dominant Polycystic Kidney
Mario Negri Institute for Pharmacological Research 91
Not applicableStudy completedNCT01348035
What this trial is testing

Efficacy Study of Water Drinking on PKD Progression.

Who this might be right for
Autosomal Dominant Polycystic Kidney DiseaseDisease Progression
Kyorin University 30
Post-approval studies (Phase 4)Study completedNCT00414440
What this trial is testing

Efficacy, Safety and Tolerability of Everolimus in Preventing End-stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney Disease

Who this might be right for
Autosomal Dominant Polycystic Kidney Disease
Novartis Pharmaceuticals 431
Not applicableActive Not RecruitingNCT06193616
What this trial is testing

Outcome of ADPKD With Octreotide LAR

Who this might be right for
Autosomal Dominant Polycystic Kidney
Mario Negri Institute for Pharmacological Research 70
Not applicableLooking for participantsNCT04630613
What this trial is testing

NOX4 and Related Biomarkers in ADPKD

Who this might be right for
Autosomal Dominant Polycystic Kidney Disease
Mayo Clinic 60
Testing effectiveness (Phase 2)Study completedNCT03487913
What this trial is testing

The ELiSA Study - Evaluation of Lixivaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease

Who this might be right for
Autosomal Dominant Polycystic Kidney Disease
Palladio Biosciences 31
Large-scale testing (Phase 3)UnknownNCT02115659
What this trial is testing

Triptolide-Containing Formulation as Treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Who this might be right for
Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Shanghai Changzheng Hospital 100
Testing effectiveness (Phase 2)Ended earlyNCT04578548
What this trial is testing

Evaluate the Effects of GLPG2737 in Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Who this might be right for
Autosomal Dominant Polycystic Kidney Disease
Lakefront Biotherapeutics NV 66
Large-scale testing (Phase 3)Study completedNCT00428948
What this trial is testing

Tolvaptan Phase 3 Efficacy and Safety Study in Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Who this might be right for
Polycystic Kidney Disease, Autosomal Dominant
Otsuka Pharmaceutical Development & Commercialization, Inc. 1,445
Not applicableStudy completedNCT02173080
What this trial is testing

Development and Assessment of The Polycystic Liver Disease Questionnaire (PLD-Q).

Who this might be right for
Polycystic Liver Disease
Mayo Clinic 594
Testing effectiveness (Phase 2)Study completedNCT01210560
What this trial is testing

Dose-finding Study of New Tolvaptan Formulation in Subjects With ADPKD

Who this might be right for
Autosomal Dominant Polycystic Kidney Disease
Otsuka Pharmaceutical Development & Commercialization, Inc. 25
Early research (Phase 1)Study completedNCT05521191
What this trial is testing

RGLS8429 in Patients With Autosomal Dominant Polycystic Kidney Disease

Who this might be right for
Autosomal Dominant Polycystic Kidney DiseaseADPKDPolycystic Kidney, Autosomal Dominant
Regulus Therapeutics Inc. 68
Testing effectiveness (Phase 2)Study completedNCT00841568
What this trial is testing

A Long-term Administration Study of OPC-41061 in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD) [Extension of Study 156-04-001]

Who this might be right for
Autosomal Dominant Polycystic Kidney Disease
Otsuka Pharmaceutical Co., Ltd. 17
Not applicableUnknownNCT02187432
What this trial is testing

The Eurocyst Initiative: Building a Network of ADPKD Reference Centers Across Europe

Who this might be right for
Autosomal Dominant Polycystic Kidney Disease
Andreas L. Serra 1,100
Not applicableUnknownNCT02729662
What this trial is testing

Efficacy of Tolvaptan on ADPKD Patients

Who this might be right for
Autosomal Dominant Polycystic Kidney Disease
Kyorin University 118
Testing effectiveness (Phase 2)Study completedNCT03203642
What this trial is testing

Study of the Efficacy and Safety of Tesevatinib in Subjects With ADPKD

Who this might be right for
Autosomal Dominant Polycystic KidneyADPKD
Kadmon, a Sanofi Company 80
Large-scale testing (Phase 3)Active Not RecruitingNCT05281328
What this trial is testing

A Trial to Assess the Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With PLD

Who this might be right for
Polycystic Liver Disease
Camurus AB 71
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation